◆ 会议时间：2021年10月26-29日
◆ 会议地点：VIRTUAL-虚拟会议
◆ 会议简介：
2021年第39届国际维琴察急性肾损伤和连续性肾脏替代治疗课程(维琴察AKI&CRRT课程)将于2021年10月26-29日举行，该课程由维琴察国际肾脏研究所(IRRIV)主办。维琴察国际课程是在安德里亚·帕拉第奥市举办的科学活动，从1982年开始，国际维琴察课程定期举行，课程拥有一流的教员和来自众多国家的与会者。课程主题是讨论重症肾脏病护理、血液透析和腹膜透析，并在实践和研究的特定领域宣进行最全面的综述。三天的课程将举行一系列讲座和小组讨论会，宗旨是将来自不同学科的专家汇集到一个科学事件中，采用多学科方法为患有急性肾损伤和多器官功能障碍的危重患者进行治疗，为来自世界各地的同行和最有经验的同事和专家提供了一个探讨危重肾脏病学最新进展和基本信息的平台（未经许可，禁止复制摘录转载本站任何内容-领域国际医学会议网）。
39th Vicenza Course on AKI & CRRT - Virtual Meeting
LANGUAGE The official language is English.
The pandemic emergency called Covid-19 (Sars-Cov-2) continues to impose measures of prevention that include social distancing, limitation of international travels and conferences where crowding would be inevitable.
For this reason, the organizing committee of the Vicenza AKI and CRRT conference 2021 has decided, in collaboration with the scientific committee, to maintain also for the 2021 edition the fully virtual modality. As last year, the special web-based platform has been further improved to ensure the perfect fruition of the scientific program, and the possibility to follow the presentations by the registered guests also a few months after the event on our educational IRRIV web site.
The course will be distributed over 4 days in which the time of scientific webinars and controversies will cover the selected topics in a series of sessions for a duration of 3-4 hours/day.
The webinars contain a compendium of current knowledge on Critical Care Nephrology and cover two main topics: 1) Acute Kidney Injury (AKI) describing the epidemiology, pathophysiology, mechanism, prevention and diagnosis through biomarkers and action strategies in different settings such as cardiac surgery, intensive care unit, cardiology, nephrology and sepsis. 2) Continuous Renal Replacement Therapies (CRRT) describing indications, modalities, prescription and delivery, different techniques and clinical results. Special emphasis will be given to conditions of kidney damage/dysfunction, sepsis, fluid overload and settings such as oncology, cardiology and cardiac surgery, trauma and sepsis, and finally septic shock. The new sorbents, membranes, machines and therapies available in this field are presented as well as new treatment strategies and recent trials in the field. Finally, a section will be dedicated to the SARS-Cov-2 pandemic and the consequences in intensive care and nephrology.
A series of lectures and panel discussions will be delivered during the days of the course. Our task is to put together specialists from different disciplines in a single scientific event with a multidisciplinary approach to the critically ill patient with acute kidney injury and multiple organ dysfunction.
Recordings containing most of the material presented at the course will be accessible for a month to participants in order to perpetuate the educational message of the course and enable those who could not take part in any of the sessions, to follow and learn off line.
For 38 years we have been a cornerstone in education and science in the field of critical care nephrology and we tried to make an important effort for a better patient care.
Companies and Members from the industry of the field are invited to join the event reserving Virtual booths and scientific spaces in between the program scientific sessions, providing additional information in areas and topics of their choice.
This is a unique event in 2021 and it will serve as a pillar for knowledge and education in the fields of AKI, CRRT and Critical Care Nephrology.
注册费：
The registration fee of 250€ (tax included) will include: attendance at the scientific sessions, attendance certificate, attendance at the sponsored symposia and at all the sponsored activities, access to on-demand contents available until December 31st 2021, access to the Q&A during the meeting
DEADLINE
Registrations will close October 22nd, 2021, h 6.00pm CET
CANCELLATION POLICY
Cancellation is possible unitl October 17th, 2021.
All the requests must be submitted by e-mail to office@npsevents.it
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
